MARKER, TUBE TYPE

The contract is for the procurement of one package of twelve Marker, Tube Type, Black, Ultra Fine Point, identified by NSN 7520-01-396-4722, sourced under solicitation SPE8EN-26-T-2688 issued by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on July 26, 2026, with a response deadline of August 6, 2026, and the delivery is required within five days after contract award to the Naval Medical Readiness and Logistics Command at Williamsburg, Virginia, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until delivery. The contract includes mandatory compliance with a broad array of Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses covering labor standards, human trafficking prevention, employment verification, sustainable products, cybersecurity safeguarding, export controls, hazardous materials handling, and prohibition of certain Chinese military company items. Packaging and marking specifications mandate commercial packaging with sealed unit containers and export-grade shipping containers; palletization is required for shipments over 250 pounds or 20 cubic feet and must adhere to MIL-STD-147 with specific Type IV or V pallet dimensions. Marking must follow Medical Marking Standard No. 1, superseding MIL-STD-129, and include NSN, government quantity, and unit of issue unless exempted by FSC categories. Passive RFID tagging is required for all shipments to DLA Distribution Locations, with exemptions for certain FSCs. Inspection and acceptance occur at the destination by the government under FAR 52.246-2, and invoicing must be processed through the Wide Area WorkFlow system. The contract includes provisions for accelerated payments to small business subcontractors, electronic payment submissions, and compliance with NIST SP 800-171 cybersecurity assessment requirements. The offeror must complete representations regarding small business status, socioeconomic certifications, unique entity identifier, and CAGE code disclosures, and must submit hazard warning labels for any controlled substances for pre-award approval. No contract value is specified in the pricing section, and no formal evaluation factors or award basis are detailed, indicating a simplified acquisition process with no formal technical evaluation beyond compliance. No attachments are listed, and details on the contracting officer or technical representative are not provided, with the point of contact for general inquiries being Jennifer Esworthy at DLA, and WAWF support accessible via the designated help